{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:29Z","timestamp":1790885549202,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1053\/j.gastro.2018.05.039","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T21:41:32Z","timestamp":1527630092000},"page":"687-695.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn\u2019s\u00a0Disease"],"prefix":"10.1053","volume":"155","author":[{"given":"Parambir S.","family":"Dulai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid S.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Chaudrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna L.","family":"Koliani-Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gursimran","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malav P.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-4092","authenticated-orcid":false,"given":"Eugenia","family":"Shmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hartke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prianka","family":"Chilukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1228-3215","authenticated-orcid":false,"given":"Joseph","family":"Meserve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hirten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah G.","family":"Katta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Peerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-8436","authenticated-orcid":false,"given":"Neeraj","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3495-012X","authenticated-orcid":false,"given":"Arun","family":"Swaminath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-2267","authenticated-orcid":false,"given":"Dana","family":"Lukin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-5271","authenticated-orcid":false,"given":"David","family":"Hudesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Rivera-Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.Y.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Feagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sandborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2018.05.039_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cgh.2012.02.004","article-title":"Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population","volume":"10","author":"Ha","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.05.039_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2016.236","article-title":"The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: results from the US VICTORY Consortium","volume":"111","author":"Dulai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.05.039_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/apt.13813","article-title":"Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease\u2014a prospective multicenter observational study","volume":"44","author":"Stallmach","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.05.039_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/j.gastro.2014.05.008","article-title":"Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed","volume":"147","author":"Sands","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","article-title":"Translating clinical research into clinical practice: impact of using prediction rules to make decisions","volume":"144","author":"Reilly","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jclinepi.2008.04.008","article-title":"Validation, updating and impact of clinical prediction rules: a review","volume":"61","author":"Toll","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/MIB.0000000000000661","article-title":"How will evolving future therapies and strategies change how we position the use of biologics in moderate to severely active inflammatory bowel disease","volume":"22","author":"Dulai","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.05.039_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib10","doi-asserted-by":"crossref","first-page":"b605","DOI":"10.1136\/bmj.b605","article-title":"Prognosis and prognostic research: validating a prognostic model","volume":"338","author":"Altman","year":"2009","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2018.05.039_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.05.039_bib13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0895-4356(03)00207-5","article-title":"External validation is necessary in prediction research: a clinical example","volume":"56","author":"Bleeker","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jclinepi.2016.02.031","article-title":"Adequate sample size for developing prediction models is not simply related to events per variable","volume":"76","author":"Ogundimu","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jclinepi.2015.02.002","article-title":"A\u00a0simulation study of sample size demonstrated the importance of the number of events per variable to develop prediction models in clustered data","volume":"68","author":"Wynants","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.5114\/aoms.2016.61915","article-title":"Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis","volume":"12","author":"Mocko","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1053\/j.gastro.2018.05.039_bib20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/MIB.0000000000000373","article-title":"Efficacy and safety of natalizumab and vedolizumab for the management of Crohn's disease: a systematic review and meta-analysis","volume":"21","author":"Chandar","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.05.039_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/aje\/kwt298","article-title":"Assessing risk prediction models using individual participant data from multiple studies","volume":"179","author":"Pennells","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0013164409344534","article-title":"Weighting by inverse variance or by sample size in random-effects meta-analysis","volume":"70","author":"Marin-Martinez","year":"2010","journal-title":"Educ Psychol Meas"},{"key":"10.1053\/j.gastro.2018.05.039_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/ecco-jcc\/jjx021","article-title":"Exposure-efficacy relationships for vedolizumab induction therapy in patients with ulcerative colitis or Crohn's disease","volume":"11","author":"Rosario","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.05.039_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/apt.13243","article-title":"Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease","volume":"42","author":"Rosario","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.05.039_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2018.05.039_bib26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2008.12.038","article-title":"Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection","volume":"136","author":"Hu","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00042737-200208000-00006","article-title":"Validation of a simplified clinical index to predict evolving patterns in Crohn's disease","volume":"14","author":"Nos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.05.039_bib28","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/ibd.21661","article-title":"Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior","volume":"17","author":"Lichtenstein","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.05.039_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/apt.13460","article-title":"A\u00a0validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables","volume":"43","author":"Siegel","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.05.039_bib30","first-page":"445","article-title":"Development and validation of risk matrices for Crohn's disease outcomes in patients who underwent early therapeutic interventions","volume":"11","author":"Dias","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.05.039_bib31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ecco-jcc\/jjv156","article-title":"A\u00a0matrix-based model predicts primary response to infliximab in Crohn's disease","volume":"9","author":"Billiet","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.05.039_bib32","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/ajg.2016.408","article-title":"Genetic markers predict primary non-response and durable response to anti-TNF biologic therapies in Crohn's disease","volume":"111","author":"Barber","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.05.039_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/apt.13083","article-title":"Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed","volume":"41","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.05.039_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MIB.0b013e31828100a4","article-title":"Effect of tumor necrosis factor-alpha blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease","volume":"19","author":"Biancheri","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2018.05.039_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2014.08.044","article-title":"Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases","volume":"147","author":"Danese","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.crohns.2010.05.011","article-title":"Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists","volume":"4","author":"Chowers","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.05.039_bib37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib38","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2016.236","article-title":"The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: results from the US VICTORY Consortium","volume":"111","author":"Dulai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.05.039_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/j.gastro.2014.05.008","article-title":"Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed","volume":"147","author":"Sands","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.05.039_bib41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0895-4356(03)00207-5","article-title":"External validation is necessary in prediction research: a clinical example","volume":"56","author":"Bleeker","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2018.05.039_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jclinepi.2016.02.031","article-title":"Adequate sample size for developing prediction models is not simply related to events per variable","volume":"76","author":"Ogundimu","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib46","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jclinepi.2015.02.002","article-title":"A\u00a0simulation study of sample size demonstrated the importance of the number of events per variable to develop prediction models in clustered data","volume":"68","author":"Wynants","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/apt.13243","article-title":"Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease","volume":"42","author":"Rosario","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.05.039_bib48","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/ecco-jcc\/jjx021","article-title":"Exposure-efficacy relationships for vedolizumab induction therapy in patients with ulcerative colitis or Crohn's disease","volume":"11","author":"Rosario","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2018.05.039_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/aje\/kwt298","article-title":"Assessing risk prediction models using individual participant data from multiple studies","volume":"179","author":"Pennells","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2018.05.039_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0013164409344534","article-title":"Weighting by inverse variance or by sample size in random-effects meta-analysis","volume":"70","author":"Marin-Martinez","year":"2010","journal-title":"Educ Psychol Meas"},{"key":"10.1053\/j.gastro.2018.05.039_bib51","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2008.12.038","article-title":"Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection","volume":"136","author":"Hu","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518345724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508518345724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T16:05:29Z","timestamp":1571414729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508518345724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0016508518345724"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2018.05.039","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn\u2019s\u00a0Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2018.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}